Sonrotoclax (BGB-11417)
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Arms / Cohorts
Experimental Arm:Part 2, Expansion: Cohorts 1 & 2
Accepting patients
Experimental:Part 2, Expansion: Cohorts 3, 4, & 5
Accepting patients
Experimental:Part 2, Expansion: Cohorts 6 & 7
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.